Variants within STAT genes reveal association with anticitrullinated protein antibody-negative rheumatoid arthritis

Maria Seddighzadeh1, Antonio Gonzalez, Bo Ding

  • 1Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. maria.seddighzadeh@ki.se

Insights

Genetic variations in STAT genes are linked to rheumatoid arthritis (RA) susceptibility. Specific STAT polymorphisms are associated with anticitrullinated protein antibody-negative RA, suggesting differential roles in disease subtypes.

Area of Science:

  • Immunogenetics
  • Rheumatology

Background:

  • Signal transducer and activator of transcription (STAT) proteins, including STAT3 and STAT4, are crucial for immune responses like the T helper 1 (Th1) response mediated by interleukin-12 (IL-12) and the survival of Th17 cells.
  • Rheumatoid arthritis (RA) is a complex autoimmune disease with distinct serological subgroups, such as those defined by the presence or absence of anticitrullinated protein antibodies (ACPA).

Purpose of the Study:

  • To investigate the association between single-nucleotide polymorphisms (SNP) in STAT3 and STAT4 genes and serologically distinct subgroups of rheumatoid arthritis (RA).

Main Methods:

  • A comprehensive analysis of 41 SNP within the STAT1-STAT4 loci was conducted in a Swedish cohort comprising 2043 RA cases and 1115 controls.
  • Nine promising SNP were further validated in an independent Spanish cohort (1223 RA cases, 1090 controls).

Main Results:

  • Fourteen SNP in STAT3 and STAT1-STAT4 loci showed significant association with ACPA-negative RA in the Swedish cohort.
  • Following validation in the Spanish cohort, three STAT4 SNP and two STAT3 SNP remained associated with ACPA-negative RA.
  • Two STAT4 SNP (rs7574865 and rs10181656) were associated with ACPA-positive RA in the Swedish cohort, with rs7574865 showing consistent association across multiple studies in a meta-analysis.

Conclusions:

  • Genetic variants within STAT genes appear to play a differential role in the susceptibility to rheumatoid arthritis, distinguishing between ACPA-positive and ACPA-negative disease phenotypes.
  • These findings highlight the potential of STAT gene polymorphisms as biomarkers for specific RA subgroups.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...